Archive for September 2019
Population pharmacokinetic – pharmacodynamic modelling of the relationship between testosterone and prostate specific antigen in patients with prostate cancer during treatment with leuprorelin
Snelder N., Drenth H.J., Riber Bergmann K., Wood N.D., Hibberd M., Scott G. Population pharmacokinetic – pharmacodynamic modelling of the relationship between testosterone and prostate specific antigen in patients with prostate cancer during treatment with leuprorelin. Br J Clin Pharmacol: 1–13, 2019. [Link to publication]
Read MoreExploration of alternative regorafenib regimens to manage hand – foot skin reaction
Ploeger B., Hoefman S., Ruppert M., Vis P., Zisowsky J., Grothey A., Cutsem E., Dochy E.v., Cleton A. Exploration of alternative regorafenib regimens to manage hand – foot skin reaction. European Society for Medical Oncology 21st World Congress on Gastrointestinal Cancer, 2019. [Link to publication]
Read MoreDirect comparison of two extended-half-life recombinant FVIII products
Shah A., Solms A., Wiegmann S., Ahsman M., Berntorp E., Tiede A., Iorio A., Mancuso M.E., Zhivkov T., Lissitchkov T. Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A. Annals of Hematology: 2035-2044, 2019. [Link to publication]
Read MorePerformance of the SAEM and FOCEI algorithms in the open-source non-linear mixed effect modelling tool nlmixr
Schoemaker R., Fidler M., Laveille C., Wilkins J. J., Hooijmaijers R., Post T. M., Trame M. N., Xiong Y., Wang W. Performance of the SAEM and FOCEI algorithms in the open-source non-linear mixed effect modelling tool nlmixr. CPT pharmacometrics Syst. Pharmacol.: 2019. [Link to publication]
Read More